- Q1 2024 Oncology Institute Inc Earnings Call TranscriptMay 14, 2024$0.9 (+3.54%)Earnings
- Q4 2023 Oncology Institute Inc Earnings Call TranscriptMar 27, 2024$1.84 (+8.88%)Earnings
- Q3 2023 Oncology Institute Inc Earnings Call TranscriptNov 08, 2023$1.84 (+5.75%)Earnings
- Q2 2023 Oncology Institute Inc Earnings Call TranscriptAug 08, 2023$1.01 (+4.12%)Earnings
- Oncology Institute Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q1 2023 Oncology Institute Inc Earnings Call TranscriptMay 10, 2023$0.5 (+4.17%)Earnings
- Q4 2022 Oncology Institute Inc Earnings Call TranscriptMar 09, 2023$1.25 (-11.35%)Earnings
- Q3 2022 Oncology Institute Inc Earnings Call TranscriptNov 09, 2022$3.1 (-4.32%)Earnings
- Q2 2022 Oncology Institute Inc Earnings Call TranscriptAug 09, 2022$6.63 (+0.61%)Earnings
- Oncology Institute Inc at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Q1 2022 Oncology Institute Inc Earnings Call TranscriptMay 11, 2022$5.62 (-14.72%)Earnings
- Q4 2021 Oncology Institute Inc Earnings Call TranscriptMar 10, 2022$4.93 (-14.56%)Earnings
Q1 2022 Oncology Institute Inc Earnings Call Transcript
Good afternoon, and welcome to the Oncology Institute's First Quarter 2022 Earnings Conference Call. Today's call is being recorded, and we have allocated 1 hour for prepared remarks and Q&A.
At this time, I'd like to turn the conference over to Mihir Shah, Chief Financial Officer at TOI. Thank you. You may begin.
Good afternoon, everyone, and thanks for joining us to discuss TOI's First Quarter 2022 Results. Before we begin, we would like to remind you that this conference call will include forward-looking statements. These statements include our future expectations regarding financial results and guidance, market opportunities and our growth. These statements are subject to various risks, uncertainties and assumptions that could cause our actual results to differ materially from these statements. These risks, uncertainties and assumptions are detailed in this afternoon's press release as well as our filings with the SEC, including our registration statement on Form S-1 that was filed with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)